Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development

Go back to Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
(NASDAQ: NKTX) Delayed: 3.23 --0 (-0%)
Previous Close $3.23    52 Week High
Open $3.23    52 Week Low
Day High $3.23    P/E N/A 
Day Low $3.23    EPS
Volume 826